factually
Index/Topics/GLP-1/GIP Agonists

GLP-1/GIP Agonists

A class of medications used to treat type 2 diabetes.

Fact-Checks

2 results
Jan 16, 2026
Most Viewed

Has any scientifically validated serum or injectable been shown to reverse Type 2 diabetes in clinical trials?

No single serum or injectable has been incontrovertibly demonstrated in clinical trials to “reverse” type 2 diabetes for broad populations; randomized‑trial evidence shows that short‑term intensive in...

Jan 5, 2026

What are the most common adverse events and discontinuation rates for tirzepatide in real‑world cohorts?

Real‑world pharmacovigilance and observational studies consistently identify gastrointestinal events—nausea, vomiting, diarrhea, constipation and dyspepsia—as the most common adverse events (AEs) with...